Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Effect of Lepodisiran on Coronary Plaque in Adults with Elevated Lipoprotein(a) and Established Atherosclerotic Cardiovascular Disease or High Risk for First Event

    Not yet recruiting

    3 1
    Investigated Drugs:
    Czechia Hungary The Netherlands Spain
  • Study of Olpasiran to prevent first major cardiovascular events in people with high levels of lipoprotein(a)

    Not yet recruiting

    3 1
    Investigated Diseases:
    Austria Belgium Bulgaria Czechia Denmark France +11
  • Study on Aspirin’s Effect on Platelet Aggregation in Patients with Type 1 Diabetes, Atherosclerotic Cardiovascular Disease, and Diabetic Kidney Disease

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    Denmark
  • Study on Colchicine and Tiemonium Methylsulphate for Reducing Atherosclerosis in Cancer Patients Undergoing Immune Therapy

    Not yet recruiting

    3 1 1 1
    The Netherlands
  • A study to evaluate the effect of muvalaplin on reducing major cardiovascular events in adults with high levels of lipoprotein(a) and atherosclerotic cardiovascular disease.

    Not recruiting

    3 1
    Investigated Diseases:
    Austria Belgium Czechia Denmark France Germany +8
  • Inclisiran for Preventing Cardiovascular Events in High-Risk Primary Prevention Patients with Atherosclerotic Cardiovascular Disease

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Belgium Bulgaria Croatia Czechia Denmark +14
  • A study to evaluate the effect of olpasiran on major cardiovascular events in patients with atherosclerotic cardiovascular disease and high levels of lipoprotein(a)

    Not recruiting

    3 1
    Austria Belgium Bulgaria Czechia Denmark Estonia +16
  • A study to evaluate the safety of MK-1403 in healthy men for the treatment of atherosclerosis

    Not recruiting

    1 1
    Investigated Diseases:
    Belgium
  • A study testing DII235 compared to placebo in adults with high lipoprotein(a) levels to reduce heart disease risk

    Not recruiting

    2 1 1
    Germany
  • A study of ziltivekimab compared to placebo in people with heart and blood vessel disease, chronic kidney disease and inflammation

    Not recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Bulgaria Croatia Czechia Denmark Germany +12